Nektar Therapeutics
Cash Flow Statement
| Line Item | FY2009 |
|---|---|
| Operating Activities | |
| Net Income | $-102.5M |
| Depreciation & Amortization | $14.9M |
| Depreciation | — |
| Amortization | — |
| Stock-Based Compensation | $10.3M |
| Net Cash from Operating Activities | $39.7M |
| Investing Activities | |
| Capital Expenditures | $16.4M |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $-149.0M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $3.5M |
| Net Change in Cash | $-106.0M |
| Free Cash Flow | $23.3M |